DD281385A5 - Verfahren zur herstellung von einem 1,3-dioxynalkansaeurederivat - Google Patents
Verfahren zur herstellung von einem 1,3-dioxynalkansaeurederivat Download PDFInfo
- Publication number
- DD281385A5 DD281385A5 DD88315013A DD31501388A DD281385A5 DD 281385 A5 DD281385 A5 DD 281385A5 DD 88315013 A DD88315013 A DD 88315013A DD 31501388 A DD31501388 A DD 31501388A DD 281385 A5 DD281385 A5 DD 281385A5
- Authority
- DD
- German Democratic Republic
- Prior art keywords
- formula
- acid
- compound
- ether
- mixture
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D319/04—1,3-Dioxanes; Hydrogenated 1,3-dioxanes
- C07D319/06—1,3-Dioxanes; Hydrogenated 1,3-dioxanes not condensed with other rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Pulmonology (AREA)
- Cardiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB878709794A GB8709794D0 (en) | 1987-04-24 | 1987-04-24 | Heterocyclic acids |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DD281385A5 true DD281385A5 (de) | 1990-08-08 |
Family
ID=10616328
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DD88315013A DD281385A5 (de) | 1987-04-24 | 1988-04-22 | Verfahren zur herstellung von einem 1,3-dioxynalkansaeurederivat |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US4921866A (ja) |
| EP (1) | EP0288279B1 (ja) |
| JP (1) | JP2620298B2 (ja) |
| KR (1) | KR880012583A (ja) |
| CN (1) | CN1015893B (ja) |
| AU (1) | AU609466B2 (ja) |
| CA (1) | CA1312084C (ja) |
| DD (1) | DD281385A5 (ja) |
| DE (1) | DE3874394T2 (ja) |
| DK (1) | DK217388A (ja) |
| FI (1) | FI881829A (ja) |
| GB (2) | GB8709794D0 (ja) |
| HU (1) | HU204522B (ja) |
| IL (1) | IL86066A (ja) |
| MY (1) | MY103368A (ja) |
| NO (1) | NO171211C (ja) |
| NZ (1) | NZ224345A (ja) |
| PL (1) | PL272024A1 (ja) |
| PT (1) | PT87301B (ja) |
| ZA (1) | ZA882528B (ja) |
| ZW (1) | ZW3888A1 (ja) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5248780A (en) * | 1988-02-16 | 1993-09-28 | Imperial Chemical Industries, Plc | Pyridyl substituted alkenoic acid derivatives |
| GB8901201D0 (en) * | 1988-02-16 | 1989-03-15 | Ici Plc | Pyridine derivatives |
| IE81170B1 (en) * | 1988-10-21 | 2000-05-31 | Zeneca Ltd | Pyridine derivatives |
| DE4018260A1 (de) * | 1990-06-07 | 1991-12-12 | Basf Ag | Derivate des (beta)-picolins und diese enthaltende pflanzenschutzmittel |
| GB9021571D0 (en) * | 1990-10-04 | 1990-11-21 | Ici Plc | Heterocyclic acids |
| CA2676437A1 (en) * | 2007-01-18 | 2008-07-24 | Evolva Sa | Substituted 1,3-dioxanes and their uses |
| DE102007010077B4 (de) | 2007-02-28 | 2010-04-08 | RUHR-UNIVERSITäT BOCHUM | [1,3]-Dioxane zur Modulation von GABAa-Rezeptoren |
| EP4190308A1 (de) | 2021-12-06 | 2023-06-07 | Marome GmbH | Schlafduft sowie herstellung und verwendung von diesem |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8310407D0 (en) * | 1982-05-12 | 1983-05-25 | Ici Plc | 1 3 - dioxan -5- ylalkenoic acids |
| GB8330120D0 (en) * | 1983-11-11 | 1983-12-21 | Ici Plc | Chemical process |
| GB8511890D0 (en) * | 1985-05-10 | 1985-06-19 | Ici Plc | Benzene derivatives |
| GR861209B (en) * | 1985-05-10 | 1986-08-29 | Ici Plc | Process for preparing novel alkene derivatives |
| GB8511896D0 (en) * | 1985-05-10 | 1985-06-19 | Ici Plc | Alkenes |
| GB8901201D0 (en) * | 1988-02-16 | 1989-03-15 | Ici Plc | Pyridine derivatives |
-
1987
- 1987-04-24 GB GB878709794A patent/GB8709794D0/en active Pending
-
1988
- 1988-04-08 GB GB888808338A patent/GB8808338D0/en active Pending
- 1988-04-11 ZA ZA882528A patent/ZA882528B/xx unknown
- 1988-04-11 ZW ZW38/88A patent/ZW3888A1/xx unknown
- 1988-04-14 IL IL86066A patent/IL86066A/xx not_active IP Right Cessation
- 1988-04-19 FI FI881829A patent/FI881829A/fi not_active Application Discontinuation
- 1988-04-19 AU AU14761/88A patent/AU609466B2/en not_active Ceased
- 1988-04-20 CA CA000564577A patent/CA1312084C/en not_active Expired - Fee Related
- 1988-04-21 EP EP88303585A patent/EP0288279B1/en not_active Expired - Lifetime
- 1988-04-21 DE DE8888303585T patent/DE3874394T2/de not_active Expired - Fee Related
- 1988-04-21 DK DK217388A patent/DK217388A/da unknown
- 1988-04-22 PL PL27202488A patent/PL272024A1/xx unknown
- 1988-04-22 NO NO881768A patent/NO171211C/no not_active IP Right Cessation
- 1988-04-22 NZ NZ224345A patent/NZ224345A/en unknown
- 1988-04-22 PT PT87301A patent/PT87301B/pt not_active IP Right Cessation
- 1988-04-22 HU HU882042A patent/HU204522B/hu not_active IP Right Cessation
- 1988-04-22 DD DD88315013A patent/DD281385A5/de not_active IP Right Cessation
- 1988-04-23 MY MYPI88000425A patent/MY103368A/en unknown
- 1988-04-23 KR KR1019880004716A patent/KR880012583A/ko not_active Application Discontinuation
- 1988-04-23 CN CN88102356A patent/CN1015893B/zh not_active Expired
- 1988-04-25 US US07/185,873 patent/US4921866A/en not_active Expired - Fee Related
- 1988-04-25 JP JP63100439A patent/JP2620298B2/ja not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| HU204522B (en) | 1992-01-28 |
| FI881829A0 (fi) | 1988-04-19 |
| GB8808338D0 (en) | 1988-05-11 |
| EP0288279A2 (en) | 1988-10-26 |
| NO171211C (no) | 1993-02-10 |
| FI881829A (fi) | 1988-10-25 |
| AU1476188A (en) | 1988-10-27 |
| NZ224345A (en) | 1991-07-26 |
| JP2620298B2 (ja) | 1997-06-11 |
| US4921866A (en) | 1990-05-01 |
| MY103368A (en) | 1993-06-30 |
| DE3874394D1 (en) | 1992-10-15 |
| CA1312084C (en) | 1992-12-29 |
| CN1015893B (zh) | 1992-03-18 |
| NO881768L (no) | 1988-10-25 |
| PT87301A (pt) | 1988-05-01 |
| JPS63280082A (ja) | 1988-11-17 |
| DK217388D0 (da) | 1988-04-21 |
| NO171211B (no) | 1992-11-02 |
| DE3874394T2 (de) | 1993-02-25 |
| EP0288279A3 (en) | 1990-05-30 |
| PL272024A1 (en) | 1989-01-23 |
| GB8709794D0 (en) | 1987-05-28 |
| NO881768D0 (no) | 1988-04-22 |
| EP0288279B1 (en) | 1992-09-09 |
| KR880012583A (ko) | 1988-11-28 |
| PT87301B (pt) | 1992-08-31 |
| CN88102356A (zh) | 1988-12-28 |
| IL86066A (en) | 1992-11-15 |
| HUT50157A (en) | 1989-12-28 |
| ZA882528B (en) | 1988-10-24 |
| IL86066A0 (en) | 1988-09-30 |
| ZW3888A1 (en) | 1989-11-22 |
| AU609466B2 (en) | 1991-05-02 |
| DK217388A (da) | 1988-10-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0546388B1 (de) | Azaheterocyclylmethyl-chromane als Wirkstoffe zur Behandlung von Erkrankungen des Zentralnervensystems | |
| DE68926144T2 (de) | Pyridinderivate | |
| DD300434A5 (de) | Heterozyklische derivate | |
| DE60128912T9 (de) | Pyridoxin- und pyridoxalanaloga als cardiovasculäre therapeutika | |
| DE3788982T2 (de) | Trans-6-[2-(N-heteroaryl)-3,5-disubstituiertes)pyrazol-4-yl)-ethyl] oder -ethenyl]tetrahydro-4-hydroxypyran-2-on-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung. | |
| DD219769A5 (de) | Verfahren zur herstellung von 1,3-dioxan-5-yl-alkansaeure-derivaten | |
| DE69008791T2 (de) | Benzopyranverbindungen, Verfahren zu ihrer Herstellung und pharmazeutische Zusammensetzungen. | |
| DE3200304A1 (de) | 3-aminopropoxyaryl-derivate, ihre herstellung und sie enthaltende arzneimittel | |
| DE3884133T2 (de) | Antihypertensive Benzopyran-Derivate. | |
| DE69217308T2 (de) | Dihydropyridine zur Anwendung in der Antitumor-Therapie | |
| DE2940833A1 (de) | 2-methyl-dihydropyridin-verbindung, verfahren zu ihrer herstellung und sie enthaltendes pharmazeutisches mittel | |
| DD281385A5 (de) | Verfahren zur herstellung von einem 1,3-dioxynalkansaeurederivat | |
| US4937242A (en) | 1,4-dihydropyridine derivatives and pharmaceutical composition thereof | |
| EP0546389B1 (de) | Piperidylmethyl substituierte Chromanderivate als Wirkstoffe zur Behandlung von Erkrankungen des Zentralnervensystems | |
| JPS60214778A (ja) | Ν置換３，４−ジヒドロピリミジン誘導体ならびにその製造法および用途 | |
| EP0749970B1 (de) | Benzisothiazolyl-substituierte Aminomethylchromane | |
| DD251749A5 (de) | Verfahren zur herstellung von 2,4-diphenyl-1,3-dioxian-derivaten | |
| DE69128254T2 (de) | Antihypertensive benzopyran-derivate | |
| DE3782378T2 (de) | Dihydropyridinderivate und deren pharmazeutische zusammensetzungen. | |
| DE68917170T2 (de) | Pyridin-Derivate. | |
| EP0539803A1 (de) | Triazaspirodecanon-Methyl-Chromane zur Bekämpfung von Erkrankungen des Zentralnervensystems | |
| US4992441A (en) | 1-[[5-[[4-substituted-1-piperazinyl]methyl]-pyrrol-2-yl or furan-2-yl]methyl-2-piperidinones useful in treating schizophrenia | |
| DE3685775T2 (de) | Alkenderivate. | |
| DE3782396T2 (de) | Pharmazeutische zusammensetzungen, enthaltend ein 2,4-diphenyl-1,3-dioxane derivat und einen inhibitor des thromboxan a2 synthese. | |
| DE2549568C3 (de) | 2,6-Dimethyl-3-methoxycarbonyl-4- (2'-nitrophenyl)-1,4-dihydropyridin-5- carbonsäureisobutylester, mehrere Verfahren zu seiner Herstellung sowie ihn enthaltende Arzneimittel |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| ENJ | Ceased due to non-payment of renewal fee |